While reversible histone modifications are linked to an ever-expanding range of biological functions [1] [2] [3] [4] [5] , the demethylases for histone H4 lysine 20 and their potential regulatory roles remain unknown. Here we report that the PHD and Jumonji C (JmjC) domain-containing protein, PHF8, while using multiple substrates, including H3K9me1/2 and H3K27me2, also functions as an H4K20me1 demethylase. PHF8 is recruited to promoters by its PHD domain based on interaction with H3K4me2/3 and controls G1-S transition in conjunction with E2F1, HCF-1 (also known as HCFC1) and SET1A (also known as SETD1A), at least in part, by removing the repressive H4K20me1 mark from a subset of E2F1-regulated gene promoters. Phosphorylation-dependent PHF8 dismissal from chromatin in prophase is apparently required for the accumulation of H4K20me1 during early mitosis, which might represent a component of the condensin II loading process. Accordingly, the HEAT repeat clusters in two non-structural maintenance of chromosomes (SMC) condensin II subunits, N-CAPD3 and N-CAPG2 (also known as NCAPD3 and NCAPG2, respectively), are capable of recognizing H4K20me1, and ChIP-Seq analysis demonstrates a significant overlap of condensin II and H4K20me1 sites in mitotic HeLa cells. Thus, the identification and characterization of an H4K20me1 demethylase, PHF8, has revealed an intimate link between this enzyme and two distinct events in cell cycle progression.
We evaluated potential substrates for the putative histone demethylase, PHF8, on mononucleosomes. Flag-tagged PHF8 immunoprecipitated from HEK293T cells was capable of demethylating H4K20me1, H3K9me1/2 and H3K27me2, but had no effects on other histone methylation marks tested. Mutation of histidine 247, predicted to be part of the Fe(II) binding site 5 , impaired these activities ( Fig. 1a ), which were similarly confirmed using bacterially expressed PHF8 (Fig. 1b , left panels) and in a dose-and time-dependent manner ( Supplementary Fig. 2a) . Surprisingly, when using core histones as substrates, whereas the activities towards H3K9me2 and H3K27me2 were preserved, only minimal activities were detected towards H4K20me1 and H3K9me1 (Fig. 1b , right panels), as similarly found for PHF8 immunoprecipitated from HEK293T cell lysates (Supplementary Fig. 2b ).
To gain insight into biological substrates of PHF8, we performed ChIP-Seq in HeLa cells, finding that ,72% of PHF8 peaks localized on promoters, with the most statistically significant predicted binding sites being those for ETS and E2F1 (Fig. 1c) . The great majority of PHF8-bound promoters overlapped with H3K4me3 (ref. 6 )-and H3K4me2-positive promoters, whereas very few harboured H4K20me1, H3K9me1/2, or H3K27me2 marks ( Fig. 1d and Supplementary Fig. 2c ). The PHF8 tags distribution relative to transcription start site corresponded to that of the H3K4me2 mark ( Fig. 1e ), indicating that PHF8 might be recruited to promoters by H3K4me2/3 on the basis of interaction with its PHD finger, a known methyl lysine binding motif 7 .
In vitro peptide pull-down showed that PHF8 bound specifically to H3K4me2 and H3K4me3 histone tails, but not to others tested (Fig. 1f ). Direct interaction of PHD finger of PHF8 with H3K4me2/3 histone tails was confirmed using bacterially expressed PHF8 PHD finger ( Fig. 1g ), whereas PHF8DPHD failed to interact ( Supplementary Fig.  2d ). Consistent with these data, PHF8DPHD retained its activities on mononucleosomes towards H3K9me2 and H3K27me2, but not towards H4K20me1 or H3K9me1 (Fig. 1h) . These results indicate a required PHD finger-mediated targeting of PHF8 to H3K4me2/3-containing nucleosomes to efficiently demethylate H4K20me1 or H3K9me1.
To evaluate PHF8 enzymatic activities in vivo, a PHF8-specific siRNA was transfected into HeLa cells, which led to significantly increased H4K20me1 levels and slightly increased H4K20me2 and H3K9me1, without changes in other histone marks ( Fig. 2a ). This H4K20me1 increase was dependent on PHF8 enzymatic activity ( Supplementary  Fig. 2e ), perhaps also partially attributed to PHF8 depletion interference with cell cycle progression (see below). Other known H3K9/K27 demethylases might compensate for the loss of PHF8, therefore minimizing PHF8 siRNA effects. Immunofluorescence microscopy analysis in HeLa cells overexpressing Flag-tagged full-length PHF8 showed that ,25% of cells had significantly decreased H4K20me1 signal intensity (n 5 200), whereas PHF8DPHD or PHF8(H247A) had no effects ( Fig. 2b and Supplementary Fig. 2f ). PHF8 overexpression caused no significant differences for other substrates ( Supplementary Fig. 2g -n). Similar results were obtained with PHF8(1-447) ( Supplementary Fig.  3a) , consistent with recent studies 8, 9 , except that we additionally observed PHF8 activity towards H4K20me1. U2OS cells overexpressing Flag-tagged full-length PHF8 showed a decrease in H4K20me1 (,20%) as well as H3K9me2 (,60%), but not in H3K9me1 or H3K27me2 signal intensity (n 5 200) ( Supplementary Fig. 3b ). Thus, PHF8 activity may be regulated both in a cell-type-dependent manner and by specific modifications [10] [11] [12] . To evaluate PHF8 enzymatic activities in HeLa cells further, ChIP-Seq analysis of H4K20me1, H3K9me1, H3K9me2 and H3K27me2 was performed in control or PHF8 siRNA-transfected HeLa cells, finding that H4K20me1 and H3K9me1, but not H3K9me2 or H3K27me2, increased significantly on PHF8-bound promoter regions upon PHF8 depletion (Fig. 2c, d and Supplementary Fig. 3c, d) . The difference in H4K20me1 and H3K9me1 levels between PHF8 siRNA-transfected and control cells correlated with the number of PHF8 ChIP-Seq tags on promoters ( Supplementary Fig. 3e , f).
We next focused on investigating the PHF8 activity towards H4K20me1, a histone mark that has been implicated in cell cycle regulation [13] [14] [15] [16] [17] . Interestingly, gene ontology analysis of PHF8-bound promoters identified by ChIP-Seq ( Fig. 1c and Supplementary Fig. 4a ) showed that one of the most statistically significant terms was 'cell cycle' ( Supplementary Fig. 4b ), as similarly found in RNA profiling analysis for genes positively regulated by PHF8 ( Supplementary Fig. 4c , d), with ,72% of which proving to be PHF8 ChIP-Seq targets. To gain further insight into PHF8 function, its associated proteins were purified, which included critical G1-S transition regulators, E2F1, HCF-1 and SET1A 18, 19 . Interactions between PHF8 and these proteins were confirmed by immunoprecipitation ( Fig. 2e ). Gel filtration chromatography revealed co-fractionation of native PHF8, E2F1, HCF-1 and SET1A ( Supplementary Fig. 4e ). Furthermore, E2F1 ChIP-Seq analysis in HeLa cells indicated that .79% of E2F1-bound promoters corresponded to those binding PHF8 ( Supplementary Fig. 5a -c), indicating a role of PHF8 in regulating E2F1 target genes.
Consistent with the potential roles of PHF8 in cell cycle regulation, PHF8 siRNA-treated HeLa cells exhibited a strikingly decreased cell proliferation ( Supplementary Fig. 6a ). Flow-cytometry analysis showed a delay in G1-S transition and revealed a slight increase in M phase population upon PHF8 knockdown ( Fig. 2f ). In addition, LETTERS there was a decrease in cell size after PHF8 siRNA treatment (Supplementary Fig. 6b ). BrdU incorporation in control or PHF8 siRNAtreated HeLa cells released from mitotic arrest confirmed that PHF8 depletion led to S phase entry delay ( Supplementary Fig. 6c, d ). To assess further PHF8 enzymatic activity at different stages during cell cycle, chromatin-bound fractions were isolated from control or PHF8 siRNA-treated HeLa cells that were synchronized following the protocols in Supplementary Fig. 6e , finding that PHF8 siRNA treatment led to a significant and distinct increase in H4K20me1 at G1-S and S phases, but exhibited minimal effects at G2-M ( Fig. 2g and Supplementary Fig. 6f , g), which was confirmed by immunofluorescence microscopy analysis ( Supplementary Fig. 6h ). Minimal effects at G2-M might be due to PHF8 dissociation from chromatin at this stage (see below). ChIP analysis on G1-S transition-regulated promoters bound by PHF8 and E2F1, including RBL1 (p107), CDC25A, CCNE1 and E2F1, showed an increase in H4K20me1 levels and a decrease in PHF8 binding upon PHF8 knockdown ( Fig. 2h and Supplementary  Fig. 7a ). The levels of H4K20me3, H3K9me1/2/3 or H3K27me1/2/3 were not significantly altered, except for an increase of H4K20me3 on the CCNE1 promoter ( Supplementary Fig. 7b -h). L3MBTL1, which has been shown to associate with H4K20me1 and function in gene repression 20 , showed increased binding ( Fig. 2i ), whereas H3K4me3 decreased upon PHF8 knockdown ( Supplementary Fig. 7i ). ChIP analysis on promoters exhibiting changes in H3K9me1 and/or H4K20me1 in ChIP-Seq experiments confirmed subsets exhibiting an increase of only H4K20me1 or H3K9me1, or both marks upon PHF8 knockdown ( Supplementary Fig. 8 ). Similarly, a change in H3K9me2 on ribosomal RNA gene promoter regions in PHF8 siRNA-treated HEK293T cells has been reported 12 . Therefore, PHF8 uses distinct substrates on different subsets of genes to exert its function.
To further elucidate the role of PHF8 in G1-S transition, we performed PHF8 ChIP-Seq in synchronized G1 and G1-S HeLa cells, revealing ,77% of binding sites at G1 localizing on promoters, as did 86% of PHF8 binding sites shared in both G1 and G1-S border. For all those shared PHF8 binding sites, ,85% showed increased PHF8 tags when cells reached G1-S border ( Fig. 3a and Supplementary Fig. 9 ), at which point H4K20me1 reaches its lowest levels 15 (Fig. 2g ). Moreover, ,13,000 new PHF8 binding sites were detected, mostly at intra-or extragenic loci (.70%), which likely mitigated the inappropriate appearance of H4K20me1 (Fig. 3a ). ChIP analysis confirmed that PHF8 binding increased on promoter regions of selected G1-S transition-regulated cell cycle genes (Fig. 3b ). In concert with association between PHF8 and HCF-1, HCF-1 was similarly recruited (Supplementary Fig. 10a ). There was also a decrease in H4K20me1 levels ( Fig. 3c ) and L3MBTL1 binding ( Fig. 3d ), but an increase in H3K4me3 ( Supplementary Fig. 10b ) during G1-S transition. Both PHF8 and HCF-1 siRNAs blocked induction of selected G1-S transition-regulated genes ( Supplementary Fig. 11 ). PHF8 and HCF-1 co-immunoprecipitated ( Fig. 3e ) and the interacting region was mapped to the amino terminus of HCF-1 (Fig. 3f ), which has been suggested to be essential for its function as G1-S transition regulator 21 , further supporting their functional interactions. Furthermore, PHF8 knockdown impaired HCF-1 and SET1A recruitment ( Fig. 3g, h) , whereas HCF-1 knockdown did not impair PHF8 recruitment ( Supplementary Fig. 12 ).
To characterize further the role of PHF8 in cell cycle regulation, we examined chromatin fractions isolated from different phases in cell cycle, confirming PHF8 disappearance from chromatin when cells enter mitosis, which correlates with an increase in H4K20me1 and Pr-Set7 (also known as SETD8; Fig. 2g and Fig. 4a ), whereas minimal or no increase in other marks was observed ( Supplementary Fig. 13a ). Immunostaining of PHF8 without pre-extraction showed no significant signal intensity change between interphase and prophase cells ( Supplementary Fig. 13b ), whereas with pre-extraction it revealed its dissociation from chromatin in prophase and re-association in telophase ( Fig. 4b) , as similarly found for green fluorescent protein (GFP)-tagged PHF8 ( Supplementary Fig. 13c ). In contrast, H4K20me1 levels increased markedly in prophase ( Supplementary  Fig. 13c, d ). PHF8 dissociation became more evident as chromosomes condensed in prophase ( Supplementary Fig. 13e ). These results indicate that PHF8 dissociation in prophase might be involved in H4K20me1 increase at this stage, as similarly proposed due to the increase of methyltransferase, Pr-Set7 (ref. 15 ). Interestingly, the five-subunit condensin II complex begins loading on chromosomes starting in prophase [22] [23] [24] [25] . Cellular fractionation showed that PHF8 dissociation from chromatin paralleled chromosomal loading of condensin II during M-phase ( Supplementary Fig. 13f ). We therefore wanted to test whether PHF8 dissociation from chromatin permits accumulation of H4K20me1 and, potentially, condensin II loading.
To test these hypotheses, we first investigated the mechanisms underlying PHF8 dissociation from chromatin. CDK1/cyclin B1 (also known as CCNB1) activity is known to fluctuate during cell cycle 26 , with its activity being inverse to PHF8 association with chromatin. In vitro kinase assays showed CDK1 phosphorylates PHF8 (Fig. 4c ). Two putative phosphorylation sites at serine 33 and 84 were identified by mass spectrometry ( Supplementary Fig. 14a, b) , and mutation at either site proved to be a poor substrate, with double mutation further diminishing the phosphorylation ( Supplementary Fig. 14c ). Inhibition of CDK activity impaired PHF8 dissociation from chromatin in mitosis ( Supplementary Fig. 14d ). Similarly, mutation of the phosphorylation sites disrupted PHF8 dissociation from chromatin and increase in H4K20me1 levels that occurred in colcemid-treated cells (Fig. 4d ). Thus, PHF8 phosphorylation at both serine 33 and 84 seems to be required for triggering its dissociation from chromatin and accumulation of H4K20me1 levels in prophase. In accord with the possibility that PHF8 dissociation from chromatin could potentially participate in condensin II loading, M-phase-synchronized cells transfected with an empty vector or wild-type PHF8, but not mutant PHF8, exhibited significant increase of chromatin-associated condensin II components compared with asynchronized cells (Fig. 4e) .
The condensin II complex from HeLa mitotic extracts was selectively pulled down by H4K20me1 and weakly by H4K20me2, but not by other histone tails tested ( Fig. 4f and Supplementary Fig. 15a ). No interaction was detected between H4K20me1 and the non-SMC subunits in the condensin I complex or one component in the cohesin complex, Rad21 (also known as RAD21), as similarly found for condensin II from asynchronized cells ( Supplementary Fig. 15b ). Furthermore, purified condensin II bound preferentially to mononucleosomes mono-methylated at H4K20 ( Supplementary Fig. 15c ).
We then asked which subunit in condensin II could mediate these interactions. As shown in Fig. 4g , N-CAPD3 strongly and N-CAPG2, to a lesser extent, interacted with H4K20me1 histone tails, but not the other three subunits. Little, if any, interaction was detected with H4K20me3 ( Supplementary Fig. 16a ). Since none of the subunits in condensin II contains known motifs associating with H4K20me1, we hypothesized that a distinct motif harboured in N-CAPD3 and N-CAPG2, the HEAT repeat [27] [28] [29] [30] , might be responsible for these events ( Supplementary Fig. 16b ). Indeed, the three predicted HEAT repeat clusters in N-CAPD3 and N-CAPG2 had interactions with H4K20me1 histone tails, with the ones from N-CAPD3 showing stronger affinity than those from N-CAPG2. In contrast, minimal, if any, interaction with H4K20me3 was detected (Fig. 4h, lanes 2, 3 and 4) . As a control, H4K20me1 histone tails failed to pull down N-CAPD3 carboxy terminus (Fig. 4h, lane 1) . Furthermore, ChIP-Seq analysis found SMC4 and H4K20me1 colocalized predominately at intra-and extragenic regions (Fig. 4i) , with ,55% of SMC4-bound regions occupied by H4K20me1 (Fig. 4j) . The specificity of a number of SMC4 binding sites was validated by ChIP-qPCR ( Supplementary Fig. 17b, c) . Given that SMC4 is present in both condensin I and II complexes, which have different distributions along chromosomes 27 , the ,55% overlap of SMC4 and H4K20me1 loci supports the specific association between H4K20me1 and condensin II.
In conclusion, our study has shown that PHF8 acts as a cell cycle regulator, at least partially based on its H4K20me1 demethylase activity ( Supplementary Fig. 1 ). The absence of PHF8 leads to a delay in G1-S transition and its dissociation from chromatin in early mitosis, which in conjunction with increased expression of Pr-Set7, leads to a surge of the H4K20me1 mark capable of interacting with the condensin II complex through the HEAT repeat clusters harboured in two non-SMC subunits, N-CAPD3 and N-CAPG2.
METHODS SUMMARY
PHF8 protein purification and demethylation assay. Flag-PHF8 proteins were expressed in HEK293T cells and cells were lysed in lysis buffer containing 50 mM Tris-HCl, pH 7.4, 450 mM NaCl, 1 mM EDTA, 1% Triton X-100 followed by sonication. High salt concentration and sonication were applied here because PHF8 is mainly and tightly associated with chromatin. Flag-PHF8 proteins were then affinity-purified by using anti-Flag M2 agarose as described in the technical bulletin (Sigma A2220) and washed extensively. Before elution with 33 Flag peptides (Sigma), the affinity resins were washed with demethylation buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 50 mM [NH 4 ] 2 Fe[SO 4 ] 2 , 1mM a-ketoglutarate and 2 mM ascorbic acid) twice. His-tagged PHF8 proteins were expressed in BL21 (DE3) bacterial cells (Stratagene) and purified by using Ni-NTA agarose (Qiagen). For demethylation reactions, PHF8 proteins were incubated with 5 mg of bulk histones (Sigma) or mononucleosomes prepared from HeLa cells in demethylation buffer at 37 uC.
Constructs, antibodies and other methods are described in the Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. glycerol, 1 mM DTT, 0.2 mM EDTA, 0.01% Tween-20) overnight at 4 uC, pulldowns were washed with washing buffer (same as incubation buffer) five times before resolving by 4-12% Bis-Tris gel (Invitrogen) and analysis by immunoblotting. Cell cycle synchronization. HeLa cells were synchronized by two sequential treatments with 2 mM thymidine (Sigma) as described previously 18 . Briefly, HeLa cells were grown in the presence of 2 mM thymidine for 12 h and then the thymidine-containing medium was replaced by normal growth medium for 11 h before the second treatment with 2 mM thymidine for another 12 h. The cells were then harvested (G1-S border) or released into normal growth medium and harvested at 4, 8, 10.5 and 15 h after release, which represent Mid S, S-G2, G2-M and Mid G1 phases, respectively. In some cases, M phase population was enriched by treating cells with colcemid (1 mM) (Sigma) for 20 h. To collect cells in S and M phases with PHF8 siRNA transfection, a modified synchronization protocol was applied (see Supplementary Fig. 6e ). Chromatin immunoprecipitation. Chromatin immunoprecipitation (ChIP) was performed as described 31 . Briefly, cells were cross-linked with 1% formaldehyde (Sigma) and chromatin DNA was sheared to 300-500 bp average in size through sonication. Resultant was immunoprecipitated with control IgG or specific antibodies overnight at 4 uC and followed by incubation with protein A Sepharose beads (Sigma) for an additional 2 h. After washing and elution, the protein-DNA complex was reversed by heating at 65 uC overnight. Immunoprecipitated DNA was purified by using QIAquick spin columns (Qiagen) and analysed by qPCR using a Stratagene Mx3000 machine. Primers used are specific for regions tested and their sequences are available on request. All ChIP and qPCRs were repeated at least three times and representative results were shown. ChIP-Seq sample preparation and computational analysis of Illumina GA I/II data were performed as follows. Asynchronized HeLa cells or cells synchronized to G1 phase or G1-S border by double thymidine block or M phase by colcemid treatment were subjected to standard ChIP, as described above. ChIP DNA samples were then subjected to preparation for ChIP-Seq Library construction: the libraries were constructed following Illumina's Chip-Seq Sample prep kit. Briefly, Chip DNA was end-blunted and added with an 'A' base so the adaptors from Illumina with a 'T' can ligate on the ends. Then 200-400 bp fragments are gel-isolated and purified. The library was amplified by 18 cycles of PCR. Primary analysis of ChIP-Seq data sets: the image analysis and base calling were performed by using Illumina's Genome Analysis pipeline. The sequencing reads were aligned to the human genome UCSC build hg18 by using BOWTIE 32 alignment programs in two ways: only uniquely aligned reads were kept or both uniquely aligned reads and the sequencing reads that align to repetitive regions were kept for downstream analysis (if a read aligns to multiple genome locations, only one location is arbitrarily chosen). The multiple reads were collapsed in order to reduce the PCR biases. The aligned reads were used for peak/island finding with MACS 33 (PHF8, E2F1 and H3K4me2 ChIP-Seq data sets) or SICER 34 (SMC4, H4K20me1, H3K9me1, H3K9me2 and H3K27me2 ChIP-Seq data sets), respectively. Both MACS and SICER peak/island predictions were adjusted for genome instabilities (amplifications, deletions) either by a considering a local background area (MACS) or a random background model (SICER) that was used as a reference for the subsequent calculation of the enrichment scores. Annotating and comparing the ChIP-Seq peaks: the ChIP-Seq peaks were mapped on the UCSC hg18 genes. A peak was considered to be associated with a particular genome feature (for example, promoter, intron and exon) if the peak summit (MACS peaks) or the middle of the peak (SICER peak) was located within 1 kb distance of TSS, or within an exon or intron. If a peak intersected with multiple genome features, all the corresponding genome features were considered when computing the genome distributions. PHF8 peaks in G1 and G1-S phases were considered common if the predicted peaks intersected over at least 1 bp. SMC4 and H4K20me1 islands in M phase were considered common if they overlap at least half of their average island length. Gene ontology analysis: the gene ontology analysis was carried out by using DAVID/EASE 35 or BINGO 36 and the sequence motif enrichment analysis was performed by using HOMER. The sequence reads for each ChIP-Seq were provided in Supplementary Fig. 18 . All the ChIP-Seq experiments were performed using samples collected from HeLa cells. Protein immunoprecipitation and immunoblotting. Cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100) and pre-cleared with protein A beads (Sigma) for 1 h before incubation with antibodies overnight at 4 uC, followed by adding protein A beads for another 2 h before washing five times with washing buffer (same as lysis buffer). Immunoprecipitates, pull-downs, cell lysates or reaction mixtures from in vitro demethylase assay or in vitro kinase assay were boiled in SDS sample buffer and resolved by 4-12% Bis-Tris NuPAGE gel (Invitrogen), transferred to nitrocellulose membrane (Bio-Rad) and western blotting was performed following standard protocols. siRNA transfection, RNA isolation and qRT-PCR. Two independent sources of siRNAs against PHF8 were validated in this study, PHF8 siRNA from Qiagen (CCGGAGACAGTGCGAACCGTA) and PHF8/ siGENOME SMARTpool from Dharmacon (M-004291-00-0005). HCF-1 (CAGCGAAATCTCAGCCTTTAA), SET1A (CAGCGTATTATGAAAGCTGGA) and SMC4 (AAGGGACTTTGTTG AACTTTA) siRNAs were purchased from Qiagen. siRNA transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. siRNA transfection efficiency was determined by immunoblotting and/or qRT-PCR. Total RNA was isolated from HeLa cells using RNeasy Mini Kit (Qiagen) following the manufacturer's protocol. First-strand cDNA synthesis from total RNA was carried out using SuperScript III (Invitrogen). Resulting cDNA was then analysed by quantitative PCR (qPCR) using Stratagene Mx3000 machine. Primers are specific for genes tested and their sequences are available upon request. All qRT-PCRs were repeated at least three times and representative results were shown. Immunofluorescence. HeLa cells transfected with expression vectors or siRNAs as indicated were pre-extracted with 0.1% Triton X-100 or directly fixed for 5 min with 4% formaldehyde in Phem buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl 2 , pH 6.9), then permeabilized for 2 min with 0.1% Triton X-100 in Phem buffer if there was no pre-extraction. After three rinses with Phem buffer, blocking solution (1% BSA in PBS, pH 7.4) was applied for 30 min and primary antibodies against Flag (Sigma, 1:1,000), PHF8 (Abcam, 1:1,000), H4K20me1 (Active Motif, 1:1,000), H4K20me2 (Abcam, 1:250), H4K20me3 (Abcam, 1:250), H3K9me1 (Abcam, 1:500), H3K9me2 (Upstate, 1:500), H3K9me3 (Abcam, 1:500), H3K27me1 (Upstate, 1:500), H3K27me2 (Abcam, 1:500) and H3K27me3 (Upstate, 1:500) were added in blocking buffer for 1 h at room temperature. After three 5-min washes with PBS/0.1% Triton X-100, cells were incubated with Hoechst dye or DAPI and with secondary doi:10.1038/nature09272 antibodies conjugated with fluorescent dyes (Jackson ImmunoResearch) for 1 h, washed again with PBS/0.1% Triton X-100, and mounted in 20 mM Tris, pH 9/0.1% p-phenylenediamine. Images were recorded on a DeltaVision microscope (Applied Precision) equipped with a CoolSnap charge-coupled device camera (Roper Scientific) at 1 3 1 binning and a 3100 NA 1.3 U-planApo objective (Olympus). Z-stacks (0.2 mm sections) were deconvolved using softWoRx (Applied Precision), projected for maximum intensity and imported into Adobe Photoshop CS4 (Adobe) for further processing. Image intensities for each antibody were scaled identically. RNA profiling. Control or PHF8 siRNAs were transfected into HeLa cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. siRNA transfection efficiency was determined by immunoblotting ( Fig. 2a ) and qRT-PCR ( Supplementary Fig. 4d ). Total RNA was isolated from HeLa cells using RNeasy Mini Kit (Qiagen) following the manufacturer's protocol with DNase I in column digestion. The microarray experiments and data normalization were performed at the UCSD BIOGEM laboratory. Briefly, RNA quality was assessed using an Agilent Bioanalyzer. Total RNA (250 ng) was labelled with biotin using the Ambion Illumina TotalPrep RNA Amplification kit. cRNA (1,500 ng) was hybridized to the Sentrix Human-6 v2 expression BeadChIP from Illumina for 18 h at 58 uC and then stained with Steptavidin-Cy3. Slides were scanned using the Illumina BeadArray Reader scanner and raw data extracted with the Illumina BeadStudio software. The data were then processed according to Illumina protocols and normalized using the multi-loess method 'mloess' as described previously 37 . Experiments were performed in duplicates. The differential expression analysis was performed by using the SAM (significance analysis of microarrays) method 38 implemented in MeV/TM 39 and in the R package 'siggenes' 40 and the FDR was sequentially set up at distinct values lower than 0.25. The gene ontology analysis was done with DAVID/EASE tools 35 (http:// david.abcc.ncifcrf.gov/). Gel filtration chromatography and purification of proteins associated with PHF8. Gel filtration chromatography was performed using a superose-6 column (Amersham Biosciences). Briefly, HeLa nuclear extracts were loaded on the equilibrated column and eluted with a buffer containing 20 mM HEPES pH 8.0, 1.5 mM MgCl 2 , 150 mM NaCl, 25% glycerol, 1 mM DTT, 0.2 mM EDTA and 1% Triton X-100. Fractions were collected in a volume of 250 ml and followed by western blotting analysis.
To purify proteins associated with PHF8, nuclear extracts were prepared from HeLa cells stably expressing Flag-PHF8 under inducible system or a control cell line in a buffer containing 20 mM HEPES pH 8.0, 1.5 mM MgCl 2 , 150 mM NaCl, 25% glycerol, 1 mM DTT, 0.2 mM EDTA, 1% Triton X-100. PHF8 associated proteins were then affinity purified by using anti-Flag M2-agarose, washed extensively and eluted with 33 Flag peptides. The eluates were concentrated and digested in solution with trypsin singles proteomic grade (Sigma) following the manufacturer's protocols and then subjected to capillary-liquid chromatography analysis. Essentially, nano-capillary columns were prepared by drawing a 360-mm outer diameter, 100-mm inner diameter deactivated, fused silica tubing (Agilent) with a Model P2000 laser puller (Sutter Instruments) (Heat: 330, 325, 320; Vel, 45; Del, 125) and were packed at 600 p.s.i. to a length of about 10 cm with C18 reverse-phase resin suspended in methanol. The column was equilibrated with 95% of solvent A (water, 0.1% acetic acid) and loaded with 10 ml (10 ng ml 21 ) of trypsin-digested reaction mix by flowing 95% of solvent A and 5% of solvent B (CH 3 CN, 0.1% acetic acid) at 200 ml min 21 for 15 min. A gradient for eluting trypsin-digested peptides was established with a time-varying solvent mixture ((min, % of solvent A): (15, 95) , (50, 60), (70, 30), (75, 5)) and electrosprayed directly into the LTQ-MS inlet (source voltage, 1.8 kV; capillary temperature, 180 uC). Two method settings were used. In both methods, the first scan was a low resolution broadband scan. The subsequent six scans were datadependent on the first scan. In each data-dependent scan, the top intensity ions excluded the ones in exclusion list were selected to be fragmented by CID which potentially, generated hundreds of fragmentation spectra collected as individual data events. In method one, the size exclusion list was set to 25 ions and a repeat of 30 s, whereas for the second method the exclusion list option was disabled. The resulting RAW files were converted to mzXML using the program ReAdW (http://tools.proteomecenter.org) and analysed with InsPecT 41 (version 2007.05.23) (http://proteomics.ucsd.edu/InspectDocs/index.html) (P # 0.3). Proteins pulled down in control samples were subtracted and the resultants were considered to be specifically associated with PHF8. Cell proliferation assay. Cell viability was measured by using a CellTiter 96 AQueous one solution cell proliferation assay kit (Promega) following the manufacturer's protocol. Briefly, 20 ml of CellTiter 96 AQueous one solution reagent was added per 100 ml of culture medium with cells transfected with siRNAs. The culture plates were incubated for 1 h at 37 uC in a humidified, 5% CO 2 atmosphere. The reaction was stopped by adding 25 ml of 10% SDS. Data was recorded at wavelength 490 nm using a CARY 3E ultraviolet-visible spectrophotometer.
